E I Du Pont De Nemours And Co  

(Public, NYSE:DD)   Watch this stock  
Find more results for DD
80.75
+0.20 (0.25%)
Real-time:   9:58AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 80.21 - 81.07
52 week 61.12 - 81.86
Open 80.40
Vol / Avg. 118,038.00/3.19M
Mkt cap 69.81B
P/E 28.32
Div/yield 0.38/1.88
EPS 2.85
Shares 864.57M
Beta 1.71
Inst. own 72%
Jan 24, 2017
Q4 2016 E I du Pont de Nemours and Co Earnings Release
Jan 24, 2017
Q4 2016 E I du Pont de Nemours and Co Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 4.78% 10.18%
Operating margin 3.91% 12.62%
EBITD margin - 19.93%
Return on average assets 2.45% 6.21%
Return on average equity 10.45% 25.61%
Employees 46,000 -
CDP Score - 99 B

Address

974 Centre Rd
WILMINGTON, DE 19805-1269
United States - Map
+1-302-7741000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

E. I. du Pont de Nemours and Company is a science and technology-based company. It operates through six segments: Agriculture, Electronics & Communications (E&C), Industrial Biosciences, Nutrition & Health, Performance Materials and Protection Solutions. Its Agriculture segment includes products, such as corn hybrids and soybean varieties, herbicides, fungicides and insecticides. Its E&C segment includes products, such as printing and packaging materials, photopolymers and electronic materials. Its Industrial Biosciences segment includes products, such as enzymes, bio-based materials and process technologies. Its Nutrition & Health segment includes products, such as probiotics, cultures, emulsifiers, natural sweeteners and soy-based food ingredients. Its Performance Materials segment includes products, such as engineering polymers, packaging and industrial polymers, films and elastomers. Its Protection Solutions segment includes products, such as nonwovens, aramids and solid surfaces.

Officers and directors

Edward D. Breen Chairman of the Board, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Nicholas Charles Fanandakis Chief Financial Officer, Executive Vice President
Age: 60
Bio & Compensation  - Reuters
James C. Collins Jr. Executive Vice President
Age: 54
Bio & Compensation  - Reuters
C. Marc Doyle Executive Vice President
Age: 47
Bio & Compensation  - Reuters
Stacy L. Fox Senior Vice President, General Counsel
Age: 63
Bio & Compensation  - Reuters
Benito Cachinero-Sanchez Senior Vice President - Human Resources
Age: 58
Bio & Compensation  - Reuters
Douglas W. Muzyka Senior Vice President and Chief Science & Technology Officer
Age: 62
Bio & Compensation  - Reuters
Lamberto Andreotti Independent Director
Age: 65
Bio & Compensation  - Reuters
Robert A. Brown Independent Director
Age: 64
Bio & Compensation  - Reuters
Alexander M. Cutler Independent Director
Age: 64
Bio & Compensation  - Reuters